Sign In
to Vote &
Create Storyboards.
 
GE stock jumps as $21.4-billion biopharma sale helps new CEO revamp the company When H. Lawrence Culp Jr. took command of flailing General Electric Co. late last year, his mandate was simple: Be more aggressive. Less than five months later, investors are applauding. The company's shares climbed Monday as Culp took his boldest step yet to rescue the troubled behemoth, agreeing...
2
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard